Aquilo Capital Management, LLC / PTGX
Aquilo Capital Management, LLC’s Protagonist Therapeutics Inc Position
Does Aquilo Capital Management, LLC own Protagonist Therapeutics Inc (PTGX)? Not currently — the last reported position was 81.7K shares worth $4M in Q1 2025; the fund’s latest 13F (Q3 2025) no longer reports it.
Position Value
$4M
Q1 2025
Shares
81.7K
% of Portfolio
+7.08%
Quarters Held
2
position exited
Position History PTGX
Reported value by quarter
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Aquilo Capital Management, LLC’s full portfolio or all institutional holders of PTGX.